SCHEMBL7299789

SCHEMBL7299789

CC1CC(=O)NN=C1c1ccc(OCCNCC(O)COc2ccccc2C#N)cc1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 14/20 0.49
HRH3 Q9Y5N1 3/20 0.46
ADRB2 P07550 1/20 0.45
ADRB3 P13945 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
ALOX15 P16050 1/20 0.45
KMT2A Q03164 1/20 0.45
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
MAOA P21397 1/20 0.43
HTR2B P41595 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303501 0.92 ADRB1 (0.49) ADRB1ADRB2ADRB3KDM4EMEN1
SCHEMBL7328370 0.86 HRH3 (0.47) ADRB1HRH3ADRB2ADRB3CYP1A2
SCHEMBL7305182 0.86 HRH3 (0.46) ADRB1HRH3ADRB2ADRB3MEN1
SCHEMBL7335463 0.85 HRH3 (0.54) ADRB1HRH3ADRB2ADRB3MEN1
SCHEMBL7397321 0.84 CYP2D6 (0.47) ADRB1ADRB2ADRB3KDM4EMEN1
SCHEMBL7306614 0.84 ADRB1 (0.52) ADRB1HRH3ADRB2ADRB3CYP1A2
SCHEMBL9686104 0.82 HRH3 (0.43) ADRB1HRH3ADRB2ADRB3CYP1A2
SCHEMBL7303996 0.82 CTSS (0.43) ADRB1ADRB2ADRB3KDM4EMEN1
SCHEMBL7304010 0.82 PDE3B (0.43) ADRB1ADRB2ADRB3KDM4EMEN1
SCHEMBL7304714 0.81 HRH3 (0.46) ADRB1HRH3ADRB2ADRB3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135932-A 2-HYDROXYPROPYLAMINO-ALKYL-BENZIMIDAZOLY-5-YL DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEART DISEASE DR. KARL THOMAE GMBH (DE) 1992-08-04 US disclosed
EP-0400519-A1 2-Hydroxy-n-propylamines, medicaments containing these compounds and method for preparing them Dr. Karl Thomae GmbH (DE) 1990-12-05 EP disclosed